These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [A case of drug-induced litholysis of a uric acid staghorn calculus in the left kidney]. Galun NM; Galun AN Lik Sprava; 1992 Mar; (3):101-3. PubMed ID: 1413669 [No Abstract] [Full Text] [Related]
43. Citrate in the management of urolithiasis. Pattaras JG; Moore RG J Endourol; 1999 Nov; 13(9):687-92. PubMed ID: 10608522 [TBL] [Abstract][Full Text] [Related]
44. [Advances and successes in the treatment of urate urolithiasis]. Hartung F Med Welt; 1966 Dec; 50():2759-62. PubMed ID: 5975592 [No Abstract] [Full Text] [Related]
45. [Indications and methods of urolitholysis therapy]. Mertz DP Dtsch Med Wochenschr; 1977 Sep; 102(38):1353-4. PubMed ID: 20302 [No Abstract] [Full Text] [Related]
46. Urinary tract calculi dissolved by means of renacidin. An experimental study. Stegmayr B; Anneroth G; Bergman B; Tomic R Scand J Urol Nephrol; 1990; 24(3):215-8. PubMed ID: 2237299 [TBL] [Abstract][Full Text] [Related]
47. [Drug-induced lysis of urinary calculi and prevention of recurrence]. Frang D; Berényi M; Babics A; Ruszinkó B; Kottász S Acta Chir Acad Sci Hung; 1969; 10(4):367-77. PubMed ID: 5372111 [No Abstract] [Full Text] [Related]
49. [Alkaline citrates in urology. A status report]. Rinnab L; Hautmann RE; Straub M Urologe A; 2004 Apr; 43(4):429-39. PubMed ID: 15085266 [TBL] [Abstract][Full Text] [Related]
50. [Acute kidney failure during drug-induced litholysis in urate calculi formation and in gout]. Müller GW; Gutschmidt HJ Munch Med Wochenschr; 1967 Jun; 109(26):1411-4. PubMed ID: 5631533 [No Abstract] [Full Text] [Related]
51. [Clinical evaluation of Uralyt-U Madaus preparation in the treatment of nephrolithiasis showing no shadows in radiograms]. Wesolowski S; Cieślak A; Milewski J; Hartel-Ulkowska N Pol Tyg Lek; 1976 Nov; 31(45):1943-6. PubMed ID: 11452 [No Abstract] [Full Text] [Related]
52. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis. Kato Y; Yamaguchi S; Yachiku S; Nakazono S; Hori J; Wada N; Hou K Urology; 2004 Jan; 63(1):7-11; discussion 11-2. PubMed ID: 14751336 [TBL] [Abstract][Full Text] [Related]
53. [Dissolution of urinary calculi by means of a solution G]. Nowiński A; Giedrojc-Juraha W Pol Przegl Chir; 1972 Feb; 44(2):Suppl:443-5. PubMed ID: 5020060 [No Abstract] [Full Text] [Related]
54. [Drug therapy of uric acid calculi of various composition]. Frang D; Berényi M; Ruszinkó B; Szendi L Orv Hetil; 1969 Jul; 110(29):1665-8. PubMed ID: 5381363 [No Abstract] [Full Text] [Related]
56. [Dissolving treatment of urinary calculi]. Thomas J; Steg A; Aboulker P Sem Ther; 1967; 43(6):405-7. PubMed ID: 5618026 [No Abstract] [Full Text] [Related]
57. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts. Sakhaee K; Nicar M; Hill K; Pak CY Kidney Int; 1983 Sep; 24(3):348-52. PubMed ID: 6645208 [TBL] [Abstract][Full Text] [Related]
58. [Alkalit Spofa]. Melich H Cas Lek Cesk; 1972 Oct; 111(44):1032-4. PubMed ID: 5084840 [No Abstract] [Full Text] [Related]
59. [Disappearance of mixed phospho-uratic calcium calculus under the effect of uralyt U]. Steckelmacher P Acta Urol Belg; 1968 Jul; 36(3):288-94. PubMed ID: 5746058 [No Abstract] [Full Text] [Related]
60. [Methods of oral litholysis by means of drugs and duration of the prevention of uric acid calculi]. Vahlensieck W Med Welt; 1970 Sep; 36():1559-66. PubMed ID: 5510243 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]